Skip to content
Healthcare
KZActiveBIN 180940018872
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 18
To risks

ТОО "МЕДИЦИНСКИЙ ЦЕНТР "ОМАРАЛИ"

Director
Имантаева Гулшахар Омаралиевна
Incorporated
17.09.2018
Address
Шымкент ЖИЛОЙ МАССИВ НУРСАТ, зд. 72/1
РНН
582000224995

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/18
Was on the KGD list of companies absent from their registered addressNot listed now

Комитет государственных доходов · data up to 14.01.2026

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses and permits

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "МЕДИЦИНСКИЙ ЦЕНТР "ОМАРАЛИ"
BIN
180940018872
Status
Active
Director
Имантаева Гулшахар Омаралиевна
Registration date
17.09.2018
Activity
Общая врачебная практика
Legal address
Шымкент ЖИЛОЙ МАССИВ НУРСАТ, зд. 72/1

In government contracts over 2 years

  • Казахстан, Шымкент, Жилой массив НУРСАТ, 72/1 matches the registered one

    contract of 20.10.2025
VAT payer
No
КАТО
791710000
РНН
582000224995
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 31 до 40 чел.

Has changed

Procurement role
Поставщик

Activities

1
86210primary

Общая врачебная практика

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
9.9M
2025
10.1M+6%
2024
9.6M+19%
2023
8.1M+50%
2022
5.4M+249%
2021
1.5M
·9.9M
2026year to date
+6%10.1M
2025
+19%9.6M
2024
+50%8.1M
2023
+249%5.4M
2022
·1.5M
2021
2026
Tax paid9,894,340 ₸
Penalty292,800 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid10,145,227 ₸
Penalty38,100 ₸
Fine39,320 ₸
VAT refund0 ₸
2024
Tax paid9,598,540 ₸
Penalty46,340 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid8,063,897 ₸
Penalty45,900 ₸
Fine36,071 ₸
VAT refund0 ₸
2022
Tax paid5,377,322 ₸
Penalty3,320 ₸
Fine77,465 ₸
VAT refund0 ₸
2021
Tax paid1,541,502 ₸
Penalty2,600 ₸
Fine95,477 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

1
  • ИГ

    Имантаева Гулшахар Омаралиевна

    Director

Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "МЕДИЦИНСКИЙ ЦЕНТР "ОМАРАЛИ" (BIN 180940018872) is an active legal entity in Шымкент, registered in 2018 (8 years on the market). Primary activity — общая врачебная практика. Per open government registries as of November 9, 2026: 2 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 1,023,000 ₸. Automated screening of open registries found no risk indicators for "МЕДИЦИНСКИЙ ЦЕНТР ". Director on record — Имантаева Гулшахар Омаралиевна. Data current as of November 9, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.